Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatProspective costs order; term extension - Gowers speaks
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
How much will it cost? asks Mr Justice Arnold
The IPKat once again thanks Lisa Chiarelli, this time for bringing his attention to the FT?s coverage of the decision by Mr Justice Arnold to require Allen & Overy to declare what its projected costs are in the battle between RIM and Visto.
The decision covers the second case between RIM and Visto. In the first case, A & O racked up over £5m in costs for a five day trial.
Mr Justice Arnold called the current costs system ?inadequate and unsatisfactory? and called for a more ?proactive? approach to controlling costs.
The IPKat (who would dearly love to see a copy of the decision) says this sounds jolly sensible. It?s fair that the losing party should have to pay costs, but if costs are allowed to spiral out of control then more defendants will be forced to settle, not because they necessarily have a bad case, but rather because of a fear of handing over a blank cheque for costs.
STOP PRESS: the full text of the decision is now available from Bailii here.
Also in the FT
Andrew Gowers? response to the
Full post as published by IPKat on December 15, 2008 (boomark / email).
Law & Order Depicts Police Procedures and Criminal Justice
Accuracy of Criminal Justice Depiction on Television
Domestic Violence
Women's Rights
Windows Software
Microsoft fined $1.3 billion for failing to comply with the European Union's antitrust order.
Pesticides
Long-Term Exposure Linked to Diabetes
Long-Term Insurance Suit
Settled for $15 Million
UnumProvident
for allegedly denying long-term disability claims.
Mississippi Antitrust
Costs Microsoft $100 Million
Austral Pacific Energy Ltd.
$1.6 million settlement reached in drilling costs dispute.

Gowers on UK Term Extension Capitulation
Synergy Wont Save Patent Term Extension For Combination of Known Drugs
USPTO Rejects SYMBICORT Patent Extension
Patently-O Bits and Bytes No. 53
Abbott prevails on patent term extension for stent
83% Chance of Patent Term Extension Due to USPTO Delay







